Dr. Ajai Chari received his medical degree from UCLA School of Medicine. He completed a residency in internal medicine at New York Presbyterian Hospital, Columbia University Medical Center, and a fellowship in hematology and oncology at the University of California, San Francisco. Dr. Chari is an Associate Professor of Medicine at Icahn School of Medicine at Mount Sinai, and Director of Clinical Research, Multiple Myeloma Program at Mount Sinai School of Medicine.

Dr. Chari is board certified in internal medicine, oncology, and hematology. He holds memberships in the American Society of Hematology, the American Society of Clinical Oncology, and the International Myeloma Working Group (IMWG), among others. His research interest is in the development of novel therapeutic agents for patients with plasma cell disorders. As a specialist in plasma cell disorders, Dr. Chari sees patients through the entire continuum of related disorders, from monoclonal gammopathies to smoldering myeloma to newly diagnosed and multi-drug refractory myeloma. He also has a large practice of rarer disorders such as AL amyloidosis and POEMS syndrome. Dr. Chari’s research and clinical efforts have resulted in numerous oral presentations at the annual meetings of ASH, ASCO, and the IMWG. He has authored/coauthored 68 scientific papers, reviews and chapters, and he has served as the international and national principal investigator (PI) of numerous studies.